Pharmaniaga Bhd 2024 Integrated Report
Company: Pharmaniaga Bhd
Sector: Manufacturing
Country: Malaysia
Year: 2024
Type: Integrated Report
Pages: 343
The report describes Pharmaniaga's FY2024 return to profitability, with revenue of RM3.8 billion and the completion and officiation of Malaysia's first locally owned biopharmaceutical plant for insulin and vaccines. The company reports a 4.17% GHG emission reduction against its 2019 baseline and discloses 6,660.77 tCO2e of Scope 3 emissions from employee commuting and business travel. Social highlights include zero workplace fatalities, while the Board comprised 27% women at year end. The report also records the first Communication on Progress under the UN Global Compact Malaysia and Brunei membership.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.